Home/Filings/4/0001179110-20-007818
4//SEC Filing

Berkenblit Anna 4

Accession 0001179110-20-007818

CIK 0000855654other

Filed

Jul 1, 8:00 PM ET

Accepted

Jul 2, 8:39 AM ET

Size

4.9 KB

Accession

0001179110-20-007818

Insider Transaction Report

Form 4
Period: 2020-06-30
Berkenblit Anna
VP & Chief Medical Officer
Transactions
  • Award

    Common Stock

    2020-06-30$3.91/sh+3,047$11,914101,136 total
Footnotes (2)
  • [F1]These shares were purchased due to participation by the reporting individual in the ImmunoGen Employee Stock Purchase Plan ("ESPP"). It pertains to the ESPP purchase period from January 1, 2020 through June 30, 2020.
  • [F2]In accordance with the ESPP; these shares were purchased based on 85% of the closing price of the issuer's common stock on June 30, 2020.

Issuer

ImmunoGen, Inc.

CIK 0000855654

Entity typeother

Related Parties

1
  • filerCIK 0001691868

Filing Metadata

Form type
4
Filed
Jul 1, 8:00 PM ET
Accepted
Jul 2, 8:39 AM ET
Size
4.9 KB